RCEL — Avita Medical Ltd

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $15.65 Analyst target: $13.58 Upside: -13.23%

About Avita Medical Ltd

AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom. The company is headquartered in Valencia, California.

See the full interactive analysis & chart →

Informational only — not investment advice.